The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TRICK-MCC: A proof-of-concept, investigator-initiated study of combination therapy with anti–PD-1, anti–LAG-3, and anti–TIM-3 in participants with advanced or metastatic PD-(L)1 refractory Merkel cell carcinoma.
 
Natalie J. Miller
No Relationships to Disclose
 
Grete Ambrazeviciute
No Relationships to Disclose
 
Wenwen Chen
No Relationships to Disclose
 
Sumia N Dakhil
Employment - UW
 
Erica Gaylord
No Relationships to Disclose
 
Evan Thomas Hall
Consulting or Advisory Role - Eisai
Research Funding - ImCheck therapeutics (Inst); Nektar (Inst); Neoleukin Therapeutics (Inst); NiKang Therapeutics (Inst); Replimune (Inst); Treatment Technologies and Insights (Inst)
 
Julia Majovski
Employment - Medtronic (I)
Stock and Other Ownership Interests - Medtronic (I)
Honoraria - Horizon CME
 
Zachary Herrin
No Relationships to Disclose
 
Samantha Kiriluk
No Relationships to Disclose
 
Paul Nghiem
Leadership - Society for Investigative Dermatology (SID)
Honoraria - UpToDate
Consulting or Advisory Role - Almirall
Research Funding - Incyte (Inst)
Patents, Royalties, Other Intellectual Property - Patent filed: "Merkel cell polyomavirus T antigen-specific TCRs and uses thereof" (Inst); Patent pending for high affinity T cell receptors that target the Merkel polyomavirus.
 
Vivian Nguyen
No Relationships to Disclose
 
Andrea Perdue
No Relationships to Disclose
 
Thomas Pulliam
Research Funding - Bristol Myers Squibb (Inst)
 
Lisa May Ling Tachiki
Travel, Accommodations, Expenses - ASCO
 
Joshua Veatch
Stock and Other Ownership Interests - Lyell Immunopharma
Research Funding - Gilead Sciences
Patents, Royalties, Other Intellectual Property - There are 3 patents on which I am an inventor that have been licensed
 
Shailender Bhatia
Stock and Other Ownership Interests - Moderna Therapeutics
Honoraria - Bristol-Myers Squibb; Incyte
Consulting or Advisory Role - Bristol Myers Squibb; Incyte
Research Funding - 4SC (Inst); Agenus (Inst); Amphivena (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); EMD Serono (Inst); Exicure (Inst); Incyte (Inst); Merck (Inst); Seven and Eight Biopharmaceuticals (Inst); TriSalus Life Sciences (Inst)